Site Map
Pfizer’s COVID-19 vaccine is first to win U.S. approval‘Poorly designed and irresponsibly run’: PPP scrutiny mounts after SBA data dumpNutrition faces a racial reckoningOracle moves its headquarters to Texas, adding to Silicon Valley exodusLive events industry lost $30 billion due to pandemicStimulus update: $600 checks are gaining supportBankers were the villains of the last recession. They can be heroes in this oneHow will tech’s biggest policy fights play out in 2021? This VC has some predictionsGSK and Sanofi shares fall as the pharma giants delay COVID-19 vaccine until late 2021Why Airbnb is great for Wall Street, but not so great for everyone elseWhy Tiffany Haddish turned down the GrammysHopes of a Brexit trade deal flash red, sending stocks and sterling lowerEurope goes all in on its net-zero pledge, backing tough new emissions targets—but not without a fightThe business community is tackling diversity with new seriousnessShopify is ready for the holiday season. Just don’t call it the ‘anti-Amazon’IPO exuberance aside, stocks are having a lousy weekWith key endorsement, Pfizer vaccine speeds toward FDA emergency approval
CareersEntertainmentVenture CapitalCoronavirusAutosChinaMarketsThe Travel IndustryEnergyA.I.BitcoinFood and DrinkSportsLuxuryPoliticsEconomyCybersecurityReal EstateRussiaStartupsDiversity and InclusionElectionsInflationChief Executive Officer (CEO)InvestingEarningsSocial MediaTaxesClimate ChangeIPOsNetflixPharmaceutical IndustryFederal ReserveLaborMergers and AcquisitionsElectric VehiclesPrivate EquityCongressHousingUnemploymentRemote WorkBanksInterest RatesMental HealthLayoffsHuman ResourcesStudent Loans and DebtGen ZWealthNutrition